ReliantHeart

About:

ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure.

Website: http://reliantheart.com

Description:

ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the HeartAssist5®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe. The HeartAssist5® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com ReliantHeart recently integrated the capacity for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the HeartAssist5® LVAD. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.

Total Funding Amount:

$10.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2013-01-01

Contact Email:

contact(AT)reliantheart.com

Founders:

Bryan Lynch, Sailesh R. Saxena

Number of Employees:

11-50

Last Funding Date:

2014-09-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai